Attached files

file filename
8-K/A - FORM 8-K/A - SCIQUEST INCsqi-8k_20130830.htm
EX-23 - EX-23.1 - SCIQUEST INCsqi-ex23_2013083013.htm
EX-99 - EX-99.1 - SCIQUEST INCsqi-ex991_2013083014.htm

Exhibit 99.2

UNAUDITED PRO FORMA COMBINED CONSOLIDATED FINANCIAL INFORMATION

On August 30, 2013, SciQuest, Inc. (“SciQuest”) acquired all of the outstanding capital stock of CombineNet, Inc. (“CombineNet”), a leading provider of advanced sourcing software. The acquisition of CombineNet expands SciQuest’s strategic sourcing footprint with an advanced, cloud-based tool that improves procurement decisions for spend categories that are typically beyond the capabilities of traditional eSourcing software. The purchase price consisted of approximately $26.6 million in cash and 819,970 shares of SciQuest’s common stock at a fair value of $17.1 million, of which $2.5 million in cash and 75,507 shares of common stock were deposited in escrow to satisfy potential indemnification claims. The purchase price is subject to an adjustment based on the closing amount of working capital of CombineNet. The acquisition was accounted for under the purchase method of accounting.

The unaudited pro forma combined consolidated balance sheet and statements of operations and accompanying notes referred to herein as the “Pro Forma Financial Statements” should be read in conjunction with:

 

·

the separate unaudited historical financial statements of SciQuest as of and for the six months ended June 30, 2013 included in SciQuest’s Quarterly Report on Form 10-Q for the six months ended June 30, 2013 and filed with the Securities and Exchange Commission on August 8, 2013;

 

·

the separate audited historical financial statements of SciQuest as of and for the year ended December 31, 2012 included in SciQuest’s Annual Report on Form 10-K for the year ended December 31, 2012 and filed with the Securities and Exchange Commission on March 8, 2013; and,

 

·

the separate unaudited historical financial statements of CombineNet as of and for the six months ended June 30, 2013 and the separate audited historical financial statements as of and for the year ended December 31, 2012, which are included in this amendment to our Current Report on Form 8-K.

The Pro Forma Financial Statements are presented for illustrative purposes only and are not indicative of either future results of operations or results that might have been achieved if the transaction had been consummated as of the date indicated. The Pro Forma Financial Statements are based upon currently available information and assumptions and estimates which SciQuest believes are reasonable. These assumptions and estimates, however, are subject to change. SciQuest’s management believes that all adjustments have been made that are necessary to fairly present the pro forma information.

   

   

   


SciQuest, Inc.

Unaudited Pro Forma Combined Consolidated Balance Sheet

As of June 30, 2013

(in thousands)

   

 

   

SciQuest, Inc.

   

   

CombineNet, Inc.

   

   

Pro Forma
Adjustments

   

   

Pro Forma
Combined

   

Assets

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Current assets:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Cash and cash equivalents

$

11,097

   

   

$

956

   

   

$

—  

   

   

$

12,053

   

Short-term investments

   

35,310

   

   

   

—  

   

   

   

(26,575

)

A

   

8,735

   

Accounts receivable, net

   

10,598

   

   

   

1,692

   

   

   

—  

   

   

   

12,290

   

Prepaid expenses and other current assets

   

1,317

   

   

   

364

   

   

   

(116

)

B

   

1,565

   

Deferred tax asset

   

90

   

   

   

—  

   

   

   

129

   

F

   

219

   

Total current assets

   

58,412

   

   

   

3,012

   

   

   

(26,562

)

   

   

34,862

   

Property and equipment, net

   

8,882

   

   

   

748

   

   

   

(361

)

C

   

9,269

   

Goodwill

   

36,553

   

   

   

—  

   

   

   

29,283

   

D

   

65,836

   

Intangible assets, net

   

14,426

   

   

   

—  

   

   

   

17,500

   

E

   

31,926

   

Deferred project costs

   

6,438

   

   

   

—  

   

   

   

116

   

B

   

6,554

   

Deferred tax asset, less current portion

   

13,929

   

   

   

—  

   

   

   

(2,156

)

F

   

11,773

   

Other

   

120

   

   

   

—  

   

   

   

—  

   

   

   

120

   

Total assets

$

138,760

   

   

$

3,760

   

   

$

17,820

   

   

$

160,340

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Liabilities and Stockholders’ Equity

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Current liabilities:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Accounts payable

$

1,220

   

   

$

464

   

   

$

—  

   

   

$

1,684

   

Accrued liabilities

   

7,597

   

   

   

515

   

   

   

—  

   

   

   

8,112

   

Line of credit

   

—  

   

   

   

500

   

   

   

(500

)

G

   

—  

   

Current maturities of long-term debt

   

—  

   

   

   

150

   

   

   

(150

)

G

   

—  

   

Deferred revenues

   

46,283

   

   

   

4,654

   

   

   

(1,187

)

I

   

49,750

   

Total current liabilities

   

55,100

   

   

   

6,283

   

   

   

(1,837

)

   

   

59,546

   

Deferred revenues, less current portion

   

13,468

   

   

   

104

   

   

   

(26

)

I

   

13,546

   

Long-term debt, less current portion

   

—  

   

   

   

187

   

   

   

(187

)

G

   

—  

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Commitments and contingencies

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Stockholders’ equity:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Common stock

   

23

   

   

   

—  

   

   

   

1

   

K

   

24

   

Preferred stock

   

—  

   

   

   

5

   

   

   

(5

)

L

   

—  

   

Additional paid-in capital

   

87,022

   

   

   

4,931

   

   

   

12,124

   

K, L

   

104,077

   

Accumulated other comprehensive loss

   

(1,147

)

   

   

(71

)

   

   

71

   

L

   

(1,147

)

Accumulated deficit

   

(15,706

)

   

   

(7,679

)

   

   

7,679

   

L

   

(15,706

)

Total stockholders’ equity

   

70,192

   

   

   

(2,814

)

   

   

19,870

   

   

   

87,248

   

Total liabilities and stockholders’ equity

$

138,760

   

   

$

3,760

   

   

$

17,820

   

   

$

160,340

   

   

   

   

   

   

   

See accompanying notes to unaudited pro forma financial statements.

   

   

   


SciQuest, Inc.

Unaudited Pro Forma Combined Consolidated Statement of Operations

For the year ended December 31, 2012

(in thousands, except per share amounts)

   

 

   

SciQuest, Inc.

   

   

CombineNet, Inc.

   

   

Pro Forma
Adjustments

   

   

Pro Forma
Combined

   

Revenues

$

66,465

   

   

$

12,399

   

   

$

(1,202

)

R

$

77,662

   

Cost of revenues

   

20,270

   

   

   

2,905

   

   

   

735

   

M, N

   

23,910

   

Gross profit

   

46,195

   

   

   

9,494

   

   

   

(1,937

)

   

   

53,752

   

Operating expenses:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Research and development

   

17,188

   

   

   

2,241

   

   

   

37

   

N

   

19,466

   

Sales and marketing

   

17,907

   

   

   

4,360

   

   

   

73

   

N

   

22,340

   

General and administrative

   

10,918

   

   

   

2,505

   

   

   

473

   

N, O

   

13,896

   

Amortization of intangible assets

   

1,268

   

   

   

—  

   

   

   

1,686

   

M

   

2,954

   

Depreciation and amortization

   

—  

   

   

   

226

   

   

   

(226

)

N, J

   

—  

   

Total operating expenses

   

47,281

   

   

   

9,332

   

   

   

2,043

   

   

   

58,656

   

(Loss) income from operations

   

(1,086

)

   

   

162

   

   

   

(3,980

)

   

   

(4,904

)

Other income (expense):

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Interest income

   

95

   

   

   

—  

   

   

   

—  

   

   

   

95

   

Interest expense

   

—  

   

   

   

(48

)

   

   

48

   

P

   

—  

   

Other expense, net

   

(82

)

   

   

(175

)

   

   

—  

   

   

   

(257

)

Total other income (expense), net

   

13

   

   

   

(223

)

   

   

48

   

   

   

(162)

   

Loss before income taxes

   

(1,073

)

   

   

(61

)

   

   

(3,932

)

   

   

(5,066

)

Income tax expense

   

(103

)

   

   

—  

   

   

   

1,489

   

S

   

1,386

   

Net loss

$

(1,176

)

   

$

(61

)

   

$

(2,443

)

   

$

(3,680

)

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Net loss per share:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Basic

$

(0.05

)

   

   

   

   

   

   

   

   

   

$

(0.16

)

Diluted

$

(0.05

)

   

   

   

   

   

   

   

   

   

$

(0.16

)

Weighted average shares outstanding used in computing per share amounts:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Basic

   

22,285

   

   

   

   

   

   

   

820

   

K

   

23,105

   

Diluted

   

22,285

   

   

   

   

   

   

   

820

   

K

   

23,105

   

   

   

   

   

   

   

   

   

   

   

See accompanying notes to unaudited pro forma financial statements.

   

   

   


SciQuest, Inc.

Unaudited Pro Forma Combined Consolidated Statement of Operations

For the six months ended June 30, 2013

(in thousands, except per share amounts)

   

 

   

SciQuest, Inc.

   

   

CombineNet, Inc.

   

   

Pro Forma
Adjustments

   

   

Pro Forma
Combined

   

Revenues

$

41,870

   

   

$

6,907

   

   

$

(19

)

Q

$

48,758

   

Cost of revenues

   

13,183

   

   

   

1,540

   

   

   

360

   

M, H

   

15,083

   

Gross profit

   

28,687

   

   

   

5,367

   

   

   

(379

)

   

   

33,675

   

Operating expenses:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Research and development

   

13,393

   

   

   

1,098

   

   

   

12

   

H

   

14,503

   

Sales and marketing

   

10,730

   

   

   

2,273

   

   

   

25

   

H

   

13,028

   

General and administrative

   

5,984

   

   

   

1,535

   

   

   

16

   

H

   

7,535

   

Amortization of intangible assets

   

943

   

   

   

—  

   

   

   

798

   

M

   

1,741

   

Depreciation and amortization

   

—  

   

   

   

108

   

   

   

(108

)

H, J

   

—  

   

Total operating expenses

   

31,050

   

   

   

5,014

   

   

   

743

   

   

   

36,807

   

(Loss) income from operations

   

(2,363

)

   

   

353

   

   

   

(1,122

)

   

   

(3,132

)

Other (expense) income:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Interest income

   

40

   

   

   

—  

   

   

   

—  

   

   

   

40

   

Interest expense

   

—  

   

   

   

(22

)

   

   

22

   

P

   

—  

   

Other (expense) income, net

   

(45

)

   

   

2,343

   

   

   

(2,343

)

Q

   

(45

)

Total other (expense) income, net

   

(5

)

   

   

2,321

   

   

   

(2,321

)

   

   

(5

)

(Loss) income before income taxes

   

(2,368

)

   

   

2,674

   

   

   

(3,443

)

   

   

(3,137

)

Income tax benefit

   

1,236

   

   

   

—  

   

   

   

291

   

S

   

1,527

   

Net (loss) income

$

(1,132

)

   

$

2,674

   

   

$

(3,152

)

   

$

(1,610

)

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Net loss per share:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Basic

$

(0.05

)

   

   

   

   

   

   

   

   

   

$

(0.07

)

Diluted

$

(0.05

)

   

   

   

   

   

   

   

   

   

$

(0.07

)

Weighted average shares outstanding used in computing per share amounts:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Basic

   

22,677

   

   

   

   

   

   

   

820

   

K

   

23,497

   

Diluted

   

22,677

   

   

   

   

   

   

   

820

   

K

   

23,497

   

   

   

   

   

   

   

   

   

   

   

   

See accompanying notes to unaudited pro forma financial statements.

   

   

   


SciQuest, Inc.

Notes to Unaudited Pro Forma Combined Consolidated Financial Statements

(in thousands)

   

1.  Basis of Pro Forma Presentation

The accompanying Pro Forma Financial Statements are based on the historical financial statements of SciQuest and CombineNet after giving effect to the acquisition of CombineNet by SciQuest using the purchase method of accounting and applying the assumptions and adjustments described in the accompanying notes.

The unaudited pro forma combined consolidated balance sheet as of June 30, 2013 gives effect to the transaction as if it had occurred on June 30, 2013. The unaudited pro forma combined consolidated statements of operations for the six months ended June 30, 2013 and the year ended December 31, 2012 give effect to the transaction as if it had occurred on January 1, 2012.

   

2.  Preliminary Purchase Price Allocation

The preliminary purchase consideration consisted of the following:

   

 

Cash

$

26,575

   

Fair value of common stock

   

17,055

   

Total purchase consideration

$

43,630

   

Cash acquired

   

1,042

   

Net purchase consideration

$

42,588

   

The purchase price was allocated on a preliminary basis to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The excess of the purchase price over the net tangible and identifiable intangible assets acquired was recorded as goodwill. The following summarizes the preliminary purchase price allocation:

   

 

   

Estimated

Useful Life

   

   

Estimated

Fair Value

   

Accounts receivable

   

   

   

   

$

2,679

   

Prepaid expenses and other current assets

   

   

   

   

   

334

   

Property and equipment

   

   

   

   

   

464

   

Deferred project costs

   

   

   

   

   

121

   

Deferred tax asset

   

   

   

   

   

5,323

   

Other assets

   

   

   

   

   

30

   

Covenant not to compete

   

2 years

   

   

   

100

   

Trademarks

   

3 years

   

   

   

300

   

Acquired technology

   

7 years

   

   

   

4,100

   

Customer relationships

   

15 years

   

   

   

13,000

   

Goodwill

   

   

   

   

   

28,811

   

Accounts payable

   

   

   

   

   

(98

)

Accrued expenses

   

   

   

   

   

(786

)

Deferred tax liability

   

   

   

   

   

(7,350

)

Deferred revenues

   

   

   

   

   

(4,440

)

Total purchase consideration

   

   

   

   

$

42,588

   

   

3.  Pro Forma Adjustments

The following pro forma adjustments are included in the unaudited pro forma combined consolidated financial statements:

(A) To reflect the cash consideration paid of $26,575.

(B) To reclassify deferred commission costs from prepaid expenses to deferred project costs, to conform to SciQuest’s basis of presentation.

(C) To reflect the fair value adjustment related to CombineNet’s capitalized software development costs.

(D) To reflect the fair value of acquired goodwill based on net assets acquired and liabilities assumed as if the acquisition occurred on June 30, 2013. The difference between the amount recorded on a pro forma basis and the actual balance as of the effective date of the


acquisition is the result of changes in the assets and liabilities of CombineNet between June 30, 2013 and the closing date of August 30, 2013.

(E) To reflect the fair value of acquired definite-lived intangible assets consisting of customer relationships of $13,000, acquired technology of $4,100, trademarks of $300, and covenants not to compete of $100.

(F) To establish deferred tax assets and liabilities related to the acquisition. Long-term deferred tax assets and liabilities of SciQuest and CombineNet are presented on a net basis.

(G) To reflect the payoff of CombineNet’s line of credit of $500, and its current and long-term outstanding debt of $150 and $187, respectively, in connection with the acquisition.

(H) To reclassify CombineNet’s depreciation expense of $70 for the six months ended June 30, 2013 to cost of revenues of $17, research and development expense of $12, sales and marketing expense of $25, and general and administrative expense of $16, to conform to SciQuest’s basis of presentation.

(I) To reflect the fair value adjustment related to CombineNet’s deferred revenue balances.

(J) To remove amortization expense of $38 and $25 for the six months ended June 30, 2013 and the year ended December 31, 2012, respectively, related to CombineNet’s capitalized software development costs.

(K) To reflect the issuance of 819,970 shares of SciQuest’s common stock with a par value of $1 and a deemed value at issuance of $17,055.

(L) To eliminate the preferred stock, additional paid-in capital, accumulated other comprehensive loss, and accumulated deficit of CombineNet.

(M) To record amortization expense related to acquired definite-lived intangible assets.

(N) To reclassify CombineNet’s depreciation expense of $201 for the year ended December 31, 2012 to cost of revenues of $49, research and development expense of $37, sales and marketing expense of $73, and general and administrative expense of $42, to conform to SciQuest’s basis of presentation.

(O) To record acquisition costs of $431.

(P) To eliminate interest expense related to outstanding debt that was paid off in connection with the acquisition.

(Q) To record a reduction of $19 and $2,343 from revenues and other income, respectively, for the six months ended June 30, 2013, related to the estimated fair value adjustment of acquired deferred revenue.

(R) To record a reduction in revenues of $1,202 for the year ended December 31, 2012, related to the estimated fair value adjustment of acquired deferred revenue.

(S) To reflect the tax effect of the pro forma adjustments described above, utilizing SciQuest’s federal and state statutory rates.